Confo Therapeutics wins support

Country

Belgium

Five years after raising €30 million in a Series A financing round, Confo Therapeutics NV has completed another fundraising – this time for €60 million to advance a pipeline of therapies that modulate G-protein coupled receptors, one of the most difficult set of targets for drug development. The new round was led by Ackermans & van Haaren and included participation from the new investors Driehaus Capital Management and Quest for Growth.